3.48 The Predictive Value of High Tumor Mutational Burden with Dr. Luc Morris

OncologyMedicineHealth Policy
Written By Kerrington .

Today we interview Dr. Luc Morris of Memorial Sloan Kettering Cancer Center on his new paper out now in JAMA Oncology titled "Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase".

Kerrington .
Previous

3.49 The Role of Government in Public Health and in COVID-19 Policy with Dr. Robert Freudenthal
Next

3.47 COVID-19 Vaccine Results, Messaging on a Patient Level, & Schools with Dr. Monica Gandhi